Histone deacetylase inhibitors in cancer therapy

This publication has 25 references indexed in Scilit:

• Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8–mediated apoptosis and down-regulation of c-FLIP protein
  Blood, 2003
• Molecular sequelae of histone deacetylase inhibition in human malignant B cells
  Blood, 2003
• Histone deacetylase inhibitors: from target to clinical trials
  Expert Opinion on Investigational Drugs, 2002
• Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) α and β messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells
  Cancer Letters, 2002
• Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
  Blood, 2002
• Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
  The EMBO Journal, 2002
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
  Nature Reviews Drug Discovery, 2002
• Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor
  Science, 2002
• Apoptosis: A Link between Cancer Genetics and Chemotherapy
  Published by Elsevier ,2002
• Translating the Histone Code
  Science, 2001